Standigm Competitors

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease. Recursion applies causative perturbations to human cells to generate disease models and associated biological image data. Recursion’s rich, relatable database of more than a petabyte of biological images generated in-house on the company’s robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics to radically improve lives. Recursion is headquartered in Salt Lake City.

Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com. Stay Alert: Avoid Recruitment Scams Across industries, cybercriminals are posing as company recruiters using fake job postings and employment offers. Please stay vigilant: - Never provide personal/financial information or payment to anyone claiming to offer a job opportunity - Always verify job postings through official company websites or direct contacts - Be cautious of unusual communication methods or overly quick offers

BenevolentAI was founded in 2013 to improve quality of life and protect our way of life through technology. That belief has guided everything we've built. Today, there's more scientific knowledge being created than any human can process. We build AI systems that help humanity make sense of it - technology that can read, reason across, and explain the world's biomedical knowledge. Our approach proved its value when our AI identified baricitinib as a potential Covid-19 treatment within 48 hours, a drug that went on to save lives globally. That wasn't about replacing scientists but extending what they could achieve. Now we're making that capability accessible to the broader life sciences ecosystem through Qor, our strategic decision intelligence platform for biotech leaders. Technology in service of life. BenevolentAI is headquartered in London, UK.